Competitive Advantage of Apex AI

The Only AI Solution for Comprehensive Gastrointestinal Cancer Screening

Apex AI stands out as the only global AI-powered diagnostic system capable of analyzing both stomach and colorectal cancer at an advanced Level 3 grading system. Unlike competitors, Apex AI provides detailed disease classification and risk stratification, making it a leader in AI-driven gastrointestinal diagnostics.

How Apex AI Compares to Competitors

Company	Target Area	Functionality	Detailed Lesion Detection & Risk Grading	AI Diagnostic Grade
Apex AI	Stomach & Colorectal	Comprehensive disease detection & severity grading	✅ 14 anatomical regions, multi-stage classification (Inflammation → Ulcers → Polyps → Early-stage → Advanced cancer)	Level 3 (Advanced AI system)
Idot	Stomach	Detects suspicious areas, marks severity	❌ Limited to six lesion types	Level 2
Weisen	Stomach	Estimates risk based on severity	❌ No anatomical mapping	Level 2
Infinite Healthcare	Colorectal	Differentiates between normal & abnormal tissue	❌ No classification of lesions	Level 1
Kaimi	Stomach & Colorectal	Detects abnormal tissue	❌ Cannot classify severity	Level 2
iScope Innovation	Stomach & Colorectal	Detects abnormal tissue	❌ Lacks lesion classification	Level 2
Kwanglim MediTech	Colorectal	Detects abnormal tissue	❌ Lacks lesion classification	Level 2

Why Apex AI is Superior

• Only AI system capable of full gastrointestinal lesion classification

• Advanced AI grading system differentiates between inflammation, ulcers, polyps, early-stage, and advanced cancer

• Applies to both stomach and colorectal cancer detection, whereas most competitors focus on a single organ

---

Key Advantages of Apex AI’s Solution

1. Broad Disease Detection

• Competing AI models mostly differentiate between normal and abnormal tissue.

• Apex AI detects the full cancer development process, from precancerous lesions to advanced cancer.

• Covers both stomach and colorectal regions, while most competitors specialize in only one.

2. Disease Progression Tracking

• Provides longitudinal disease tracking, allowing physicians to monitor lesion evolution over time.

• Enhances treatment planning and patient lifestyle recommendations based on risk assessment.

3. Unmatched Diagnostic Accuracy

• Apex AI achieves 95% accuracy for stomach cancer and 98% accuracy for colorectal cancer.

• This surpasses competing AI models, which typically lack large-scale datasets and detailed lesion classification.

4. Future Expansion: AI-Driven Dietary Management

• Apex AI is developing AI-powered dietary analysis to enhance digestive health monitoring.

• Future integration will provide dietary recommendations for cancer prevention and treatment.

---

Technological Superiority: Why Apex AI Leads in AI-Powered Diagnostics

1. Five Years of AI Algorithm Refinement

• Continuous optimization has led to superior performance, with stomach cancer detection reaching 95% accuracy and colorectal cancer detection achieving 98% accuracy.

2. World’s Largest Gastrointestinal Endoscopy AI Dataset

• Trained on over 1 million endoscopic images, making it the most comprehensive AI system for gastrointestinal cancer.

• Overcomes biases found in small-scale datasets, ensuring robust AI predictions.

3. Multi-Modal AI Data Fusion

• Integrates endoscopic imaging with numerical health data, improving AI-driven clinical decision-making.

• Fusion of visual and statistical data enhances diagnostic precision and reliability.

---

Apex AI: Leading the Future of AI-Powered Gastrointestinal Cancer Detection

With superior lesion classification, unmatched accuracy, and long-term disease tracking, Apex AI is redefining cancer diagnostics. Our mission is to provide AI-powered, life-saving early detection for patients worldwide.